Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy
NCT00757250
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
13
Enrollment
INDUSTRY
Sponsor class
Stopped
Difficulty recruiting subjects to dosing cohort 5.
Conditions
HIV Infections
Interventions
DRUG:
Angiotensin 1-7
Sponsor
US Biotest, Inc.
Collaborators
[object Object]